Related Experiment Video
Updated: Jun 6, 2025

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Gold metallene-based ECL biosensor to detect miRNA-126 for coronary artery calcification diagnosis
Fengwen Cui1, Weiwei Chen1, Peilin Wang2
1Department of Cardiovascular Medicine, China-Japan Union Hospital of Jilin University, Changchun, 130033, China.
Abstract:
Coronary artery calcification (CAC) is a pathological change and independent risk factor in cardiovascular diseases. In this work, a gold-based metallene structure was prepared as sensing interface based on mPEG-SH modified Au nanoparticles for the CAC detection. Firstly, a novel nanovesicle was self-assembled with excellent conductivity. The nanovesicles can confine copper nanoclusters and restrict the intramolecular rotation and vibration of copper nanoclusters. So, the luminescence nanovesicle-based confined-induced electrochemiluminescence (ECL) nanoprobe was prepared. Secondly, a novel Au metallene material was constructed by thermally treating the mPEG-SH modified Au NPs. The disulfide bonds provided a stable cross-linked network of Au nanoparticles to form Au metallene with exceptional electron transfer capacity and abundant active sites, which significantly enhanced the ECL intensity of luminescence nanovesicle. Finally, the sensing system was established with DNA catalytic hairpin assembly technology to detect miR-126-3p in the CAC patients' plasma. Combining with the vascular calcification scores obtained from intravenous ultrasound during interventions, the results showed that miR-126-3p can be used as a biomarker for diagnosing CAC lesions. Moreover, the constructed biosensing system had a better AUC value (0.967) over that of the classical PCR method. This Au metallene-based ECL sensor provided an inspiring plasma sample detection strategy for the early screening and auxiliary diagnosis of CAC patients.
More Related Videos
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017